Lavrentaki A, Paluzzi A, Wass JAH, Karavitaki N (2017) Epidemiology of acromegaly: review of population studies. Pituitary 20(1):4–9. https://doi.org/10.1007/s11102-016-0754-x
Article PubMed PubMed Central Google Scholar
Crisafulli S, Luxi N, Sultana J et al (2021) Global epidemiology of acromegaly: a systematic review and meta-analysis. Eur J Endocrinol 185(2):251–263. https://doi.org/10.1530/EJE-21-0216
Article CAS PubMed Google Scholar
Fleseriu M, Langlois F, Lim DST, Varlamov EV, Melmed S (2022) Acromegaly: pathogenesis, diagnosis, and management. Lancet Diabetes Endocrinol 10(11):804–826. https://doi.org/10.1016/S2213-8587(22)00244-3
Article CAS PubMed Google Scholar
Bolfi F, Neves AF, Boguszewski CL, Nunes-Nogueira VS (2018) Mortality in acromegaly decreased in the last decade: a systematic review and meta-analysis. Eur J Endocrinol 179(1):59–71. https://doi.org/10.1530/EJE-18-0255
Article CAS PubMed Google Scholar
Dekkers OM, Biermasz NR, Pereira AM, Romijn JA, Vandenbroucke JP (2008) Mortality in acromegaly: a metaanalysis. J Clin Endocrinol Metab 93(1):61–67. https://doi.org/10.1210/jc.2007-1191
Article CAS PubMed Google Scholar
Fleseriu M, Biller BMK, Freda PU et al (2021) A pituitary society update to acromegaly management guidelines. Pituitary 24(1):1–13. https://doi.org/10.1007/s11102-020-01091-7
Marques-Pamies M, Gil J, Sampedro-Nuñez M et al (2024) Personalized medicine in acromegaly: the ACROFAST study. J Clin Endocrinol Metab 110(1):30–40. https://doi.org/10.1210/clinem/dgae444
Article CAS PubMed PubMed Central Google Scholar
Zanier O, Zoli M, Staartjes VE et al (2022) Machine learning-based clinical outcome prediction in surgery for acromegaly. Endocrine 75(2):508–515. https://doi.org/10.1007/s12020-021-02890-z
Article CAS PubMed Google Scholar
Lim DST, Fleseriu M (2022) Personalized medical treatment of patients with acromegaly: a review. Endocr Pract 28(3):321–332. https://doi.org/10.1016/j.eprac.2021.12.017
Gliga MC, Chinezu L, Pascanu IM (2024) Predicting response to medical treatment in acromegaly via granulation pattern, expression of somatostatin receptors type 2 and 5 and E-Cadherin. Int J Mol Sci 25(16):8663. https://doi.org/10.3390/ijms25168663
Article CAS PubMed PubMed Central Google Scholar
Marazuela M, Martínez-Hernandez R, Marques-Pamies M, Biagetti B, Araujo-Castro M, Puig-Domingo M (2024) Predictors of biochemical response to somatostatin receptor ligands in acromegaly. Best Pract Res Clin Endocrinol Metab 38(4):101893. https://doi.org/10.1016/j.beem.2024.101893
Article CAS PubMed Google Scholar
Bando H, Sano T, Ohshima T et al (1992) Differences in pathological findings and growth hormone responses in patients with growth hormone-producing pituitary adenoma. Endocrinol Jpn 39(4):355–363. https://doi.org/10.1507/endocrj1954.39.355
Article CAS PubMed Google Scholar
Yamada S, Aiba T, Sano T et al (1993) Growth hormone-producing pituitary adenomas: correlations between clinical characteristics and morphology. Neurosurgery 33(1):20–27. https://doi.org/10.1227/00006123-199307000-00003
Article CAS PubMed Google Scholar
Mazal PR, Czech T, Sedivy R et al (2001) Prognostic relevance of intracytoplasmic cytokeratin pattern, hormone expression profile, and cell proliferation in pituitary adenomas of akromegalic patients. Clin Neuropathol 20(4):163–171
Obari A, Sano T, Ohyama K et al (2008) Clinicopathological features of growth hormone-producing pituitary adenomas: difference among various types defined by cytokeratin distribution pattern including a transitional form. Endocr Pathol 19(2):82–91. https://doi.org/10.1007/s12022-008-9029-z
Bakhtiar Y, Hirano H, Arita K et al (2010) Relationship between cytokeratin staining patterns and clinico-pathological features in somatotropinomae. Eur J Endocrinol 163(4):531–539. https://doi.org/10.1530/EJE-10-0586
Article CAS PubMed Google Scholar
Fougner SL, Casar-Borota O, Heck A, Berg JP, Bollerslev J (2012) Adenoma granulation pattern correlates with clinical variables and effect of somatostatin analogue treatment in a large series of patients with acromegaly. Clin Endocrinol (Oxf) 76(1):96–102. https://doi.org/10.1111/j.1365-2265.2011.04163.x
Article CAS PubMed Google Scholar
Brzana J, Yedinak CG, Gultekin SH, Delashaw JB, Fleseriu M (2013) Growth hormone granulation pattern and somatostatin receptor subtype 2A correlate with postoperative somatostatin receptor ligand response in acromegaly: a large single center experience. Pituitary 16(4):490–498. https://doi.org/10.1007/s11102-012-0445-1
Article CAS PubMed Google Scholar
Larkin S, Reddy R, Karavitaki N, Cudlip S, Wass J, Ansorge O (2013) Granulation pattern, but not GSP or GHR mutation, is associated with clinical characteristics in somatostatin-naive patients with somatotroph adenomas. Eur J Endocrinol 168(4):491–499. https://doi.org/10.1530/EJE-12-0864
Article CAS PubMed Google Scholar
Mori R, Inoshita N, Takahashi-Fujigasaki J et al (2013) Clinicopathological features of growth hormone-producing pituitary adenomas in 242 acromegaly patients: classification according to hormone production and cytokeratin distribution. ISRN Endocrinol 2013:723432. https://doi.org/10.1155/2013/723432
Article CAS PubMed PubMed Central Google Scholar
Mayr B, Buslei R, Theodoropoulou M, Stalla GK, Buchfelder M, Schöfl C (2013) Molecular and functional properties of densely and sparsely granulated GH-producing pituitary adenomas. Eur J Endocrinol 169(4):391–400. https://doi.org/10.1530/EJE-13-0134
Article CAS PubMed Google Scholar
Swanson AA, Erickson D, Donegan DM et al (2021) Clinical, biological, radiological, and pathological comparison of sparsely and densely granulated somatotroph adenomas: a single center experience from a cohort of 131 patients with acromegaly. Pituitary 24(2):192–206. https://doi.org/10.1007/s11102-020-01096-2
Article CAS PubMed Google Scholar
Sarkar S, Chacko AG, Chacko G (2014) An analysis of granulation patterns, MIB-1 proliferation indices and p53 expression in 101 patients with acromegaly. Acta Neurochir 156(12):2221–2230. https://doi.org/10.1007/s00701-014-2230-6
Giustina A, Barkan A, Beckers A et al (2020) A consensus on the diagnosis and treatment of acromegaly comorbidities: an update. J Clin Endocrinol Metab 105(4):e937–e946. https://doi.org/10.1210/clinem/dgz096
Akirov A, Masri-Iraqi H, Dotan I, Shimon I (2021) The biochemical diagnosis of acromegaly. J Clin Med 10(5):1147. https://doi.org/10.3390/jcm10051147
Article CAS PubMed PubMed Central Google Scholar
Katznelson L, Laws ER, Melmed S et al (2014) Acromegaly: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 99(11):3933–3951. https://doi.org/10.1210/jc.2014-2700
Article CAS PubMed Google Scholar
Shah R, Bansal D, Rastogi P et al (2025) Normative data for insulin-like growth factor-1 and insulin-like growth factor binding protein-3 and their determinants in healthy adult males from india: the INDIIGo study. Sci Rep 15(1):41340. https://doi.org/10.1038/s41598-025-25235-6
Article CAS PubMed PubMed Central Google Scholar
Ravi Teja KV, Malhotra B, Vogel M et al (2024) Normative data for insulin-like growth factor 1 in healthy children and adolescents from India. J Clin Endocrinol Metab 109(12):3146–3155. https://doi.org/10.1210/clinem/dgae340
Comments (0)